Amgen Inc. sell Rothschild & Co Redburn
Start price
18.02.26
/
50%
€314.70
Target price
18.02.27
€168.84
Performance (%)
15.97%
Price
13.08.26
€362.45
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 15.97%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 18.02.27. The prediction end date can be changed by Rothschild___Co_Redb at any time. Rothschild___Co_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 2.337% | 2.337% |
| iShares Core DAX® | 0.625% | 4.952% |
| iShares Nasdaq 100 | 1.160% | -1.160% |
| iShares Nikkei 225® | 2.356% | -1.354% |
| iShares S&P 500 | 0.631% | 1.380% |
Comments by Rothschild___Co_Redb for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Rothschild & Co Redburn from $180.00 to $200.00. They now have a "sell" rating on the stock.
Ratings data for AMGN provided by MarketBeat

